Archive April 7, 2014 Deciphera Pharmaceuticals Announces Initiation of Phase 1 Cancer Trial for LY3009120 Pan-RAF Inhibitor Created and Developed in Collaboration with Eli Lilly
Archive April 7, 2014 Deciphera Pharmaceuticals Appoints Michael D. Taylor, Ph.D., as President and Chief Executive Officer
Archive March 17, 2014 Deciphera Pharmaceuticals Presents Preclinical Data on Rebastinib and DCC-3014 at AACR Tumor Microenvironment Conference
Archive August 5, 2013 Deciphera announces appointment of John de Groot, MD to its Scientific Advisory Board
Archive July 27, 2013 Deciphera announces appointment of John Condeelis to its Scientific Advisory Board
Archive October 4, 2012 Deciphera Pharmaceuticals Announces Transition to an Oncology Drug Development Company
Archive June 11, 2012 Deciphera Pharmacueticals Announces Appointment of Kapil Bhalla, MD to its Scientific Advisory Board
Archive April 26, 2012 Deciphera Pharmaceuticals Announces Appointment of Dr. Patrick O’Connor to its Scientific Advisory Board
Archive February 1, 2012 Deciphera Pharmaceuticals Announces Collaboration Milestone with Eli Lilly and Company
